Πέμπτη 9 Φεβρουαρίου 2017

Phase 2 study of eribulin in patients with previously treated advanced or metastatic soft tissue sarcoma†.

Related Articles

Phase 2 study of eribulin in patients with previously treated advanced or metastatic soft tissue sarcoma†.

Jpn J Clin Oncol. 2017 Feb 01;47(2):137-144

Authors: Kawai A, Araki N, Naito Y, Ozaki T, Sugiura H, Yazawa Y, Morioka H, Matsumine A, Saito K, Asami S, Isu K

PMID: 28173193 [PubMed - in process]



http://ift.tt/2luf4pL

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου